Related Experiment Video
Updated: Jan 21, 2026

Culture of Bladder Cancer Organoids as Precision Medicine Tools
Published on: December 28, 2021
Driving towards Precision Medicine for angioedema without wheals
Anastasios E Germenis1, Marco Cicardi2
1Department of Immunology & Histocompatibility, School of Medicine, University of Thessaly, Larissa, Greece.
Recurrent angioedema without wheals is more complex than previously thought, with new genetic variants identified. High-throughput approaches are needed for better understanding and personalized treatment of this rare disease.
Area of Science:
- Genetics
- Immunology
- Rare Diseases
Background:
- Recurrent angioedema without wheals is a complex group of disorders.
- Recent discoveries reveal novel genetic variants beyond SERPING1 and F12.
- One variant suggests a new endotype not reliant on bradykinin.
Purpose of the Study:
- To review recent data on angioedema complexity.
- To advocate for a shift towards high-throughput research methods.
- To highlight the benefits of precision medicine for angioedema.
Main Methods:
- Review of recent genetic and functional studies.
- Analysis of novel gene variants associated with hereditary angioedema.
- Discussion of high-throughput approaches for disease research.
Main Results:
- Identification of novel gene variants (e.g., ANGPT1) in hereditary angioedema.
- Evidence for a new disease endotype independent of bradykinin.
- Conventional research methods are insufficient to elucidate disease complexity.
Conclusions:
- Angioedema research requires a paradigm shift to high-throughput methodologies.
- Precision medicine offers a promising future for personalized patient management.
- A deeper understanding of angioedema's complexity is crucial for effective treatment.
Related Concept Videos
Energy to Drive Translocation
Generally, polypeptides are unfolded by two distinct...
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
Uncertainty in Measurement: Accuracy and Precision
Accuracy and Precision
Microorganisms in Medicine and Therapeutics
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

